Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DUK vs GSK✓SelectedUSD · GSKDUK vs GSK performance historyLatest closeAs of-0.92%11/19
Stock and ETF performance explorer

DUK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+58.5%
GSK return
+39.6%
Excess return
+19.0%
Maximum drawdown
-24.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.9%-1.6%+0.6%-0.6%
7D+1.1%-4.7%+5.8%+2.1%
30D+7.1%-4.7%+11.8%+8.2%
3M+5.1%-8.8%+13.9%+7.0%
6M+5.2%-4.6%+9.9%+6.1%
YTD+13.8%+1.0%+12.8%+12.8%
1Y+9.1%+6.9%+2.2%+6.8%
3Y+59.8%+52.5%+7.2%+40.8%
5Y+58.5%+40.3%+18.3%+35.9%
All+58.5%+39.6%+19.0%+35.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling